Tygacil 50 mg/5mL
TIGECYCLINE · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
Tygacil is a injection, powder, lyophilized, for solution containing tigecycline at 50 mg/5mL, taken intravenous. Manufactured by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc..
Key Facts
- Brand Name
- Tygacil
- Generic Name
- TIGECYCLINE
- NDC Code (Product)
0008-4994- Manufacturer
- Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
- Strength
- 50 mg/5mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- NDA021821
- Drug Class
- Tetracycline-class Antibacterial [EPC]
- Marketing Start
- 02/08/2017
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Frequently Asked Questions
What is Tygacil used for?
Tygacil contains TIGECYCLINE. It is a injection, powder, lyophilized, for solution taken intravenous. Consult your doctor for specific uses.
Is Tygacil a controlled substance?
Tygacil is not classified as a controlled substance by the DEA.
What is the generic name for Tygacil?
The generic name for Tygacil is TIGECYCLINE. There are 5 other brand versions of TIGECYCLINE.
What is the NDC code for Tygacil 50 mg/5mL?
The NDC (National Drug Code) for Tygacil 50 mg/5mL is 0008-4994, listed by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc..